期刊文献+

恶性肿瘤患者尿中修饰核苷的检测 被引量:1

Detection of Urinary Modified Nucleosides in Patients with Malignancies
下载PDF
导出
摘要 应用毛细管电泳法分别对35名健康成人及32名恶性肿瘤患者尿中13种核苷进行检测 ,结果肿瘤患者的平均值比健康人明显升高 ,提示其可用于恶性肿瘤的辅助诊断。
出处 《肿瘤学杂志》 CAS 2003年第1期57-58,共2页 Journal of Chinese Oncology
基金 中国科学院知识创新工程前沿项目资助 (DICKaaaabc)
  • 相关文献

参考文献4

  • 1[1]Xu G, Stefano CD, Liebich HM, et al. Reversed_phase high_performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients[J]. J Chromatogr,1999, 732: 307-313.
  • 2[2]Liebich HM, Xu GW, Stefanoc CD, et al. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patient[J]. J Chromatogr, 1998, 793: 341-347.
  • 3[3]Torgny R, Glenn RB.Urinary excretion of pseudouridine and prognosis of patients with malignant lyphoma[J]. Acta Oncologica,1995, 34: 61-67.
  • 4[4]Xu G, Schmid HR, Lu X,et al. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP HPLC and factor analysis method[J]. Biomed Chromatogr, 2000, 4:1-5.

同被引文献38

  • 1顾祖维.现代毒理学的研究方法进展及其热点[J].中国公共卫生,2005,21(2):254-256. 被引量:6
  • 2沈朋,曾真,程翼宇.乳腺癌血清蛋白质组与尿代谢物组协同分析研究[J].中华检验医学杂志,2005,28(7):710-712. 被引量:10
  • 3梅素容,王鹏,吴采樱,周宜开.GC/MS法测定尿中的8-羟基脱氧鸟苷[J].华中科技大学学报(自然科学版),2006,34(5):118-120. 被引量:12
  • 4Nicholson JK,Connelly J,Lindon JC,et al.Metabonomics:a platform for studying drug toxicity and gene function[J].Nat Rev Drug Discov,2002,1:153-162.
  • 5Mountford CE,Doran S,Lean CL,et al.Cancer pathology in the year 2000[J].Biophy Chem,1997,68:127-135.
  • 6Brindle JT,Antti H,Holmes E,et al.Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics[J].Nat Med,2002,8:1439-1444.
  • 7Kostara CH,Papathanasiou A,Cung MT,et al.Total plasma lipid analysis in patients with established coronary heart disease by 1H-NMR spectroscopy[C].75th EAS Congress,2005.23-26.
  • 8Bathen TF,Engan T,Krane J,et al.Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD[J].Anticancer Res,2000,20(4):2393-2408.
  • 9Bowden RG,Leutholtz BC,Wilson R,et al.NMR Lipoprofile,changing the way coronary heart disease(CHD) lipoprofile is Assessed and managed in end-stage renal disease[J].Med Sci in Sports Exere,2004,36(5):160.
  • 10Howells SL,Maxwell RJ,Howe FA,et al.Pattern recognition of 31P magnetic resonance spectroscopy tumor spectra obtained in vivo[J].NMR Biomed,1993,6(4):237-241.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部